These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 34750377)
1. Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood. Levy MA; Beck DB; Metcalfe K; Douzgou S; Sithambaram S; Cottrell T; Ansar M; Kerkhof J; Mignot C; Nougues MC; Keren B; Moore HW; Oegema R; Giltay JC; Simon M; van Jaarsveld RH; Bos J; van Haelst M; Motazacker MM; Boon EMJ; Santen GWE; Ruivenkamp CAL; Alders M; Luperchio TR; Boukas L; Ramsey K; Narayanan V; Schaefer GB; Bonasio R; Doheny KF; Stevenson RE; Banka S; Sadikovic B; Fahrner JA NPJ Genom Med; 2021 Nov; 6(1):92. PubMed ID: 34750377 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis of TET3-Related Beck-Fahrner Syndrome in an Individual With Chorioretinal and Iris Colobomata Using a DNA Methylation Signature. Man A; Di Scipio M; McConkey H; Hough R; Stein N; Diehl E; Marshall CR; Sadikovic B; Ejaz R Am J Med Genet A; 2024 Sep; ():e63864. PubMed ID: 39324309 [TBL] [Abstract][Full Text] [Related]
3. Delineation of a Human Mendelian Disorder of the DNA Demethylation Machinery: TET3 Deficiency. Beck DB; Petracovici A; He C; Moore HW; Louie RJ; Ansar M; Douzgou S; Sithambaram S; Cottrell T; Santos-Cortez RLP; Prijoles EJ; Bend R; Keren B; Mignot C; Nougues MC; Õunap K; Reimand T; Pajusalu S; Zahid M; Saqib MAN; Buratti J; Seaby EG; McWalter K; Telegrafi A; Baldridge D; Shinawi M; Leal SM; Schaefer GB; Stevenson RE; Banka S; Bonasio R; Fahrner JA Am J Hum Genet; 2020 Feb; 106(2):234-245. PubMed ID: 31928709 [TBL] [Abstract][Full Text] [Related]
5. Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole blood. Levy MA; Beck DB; Metcalfe K; Douzgou S; Sithambaram S; Cottrell T; Ansar M; Kerkhof J; Mignot C; Nougues MC; Keren B; Moore HW; Oegema R; Giltay JC; Simon M; van Jaarsveld RH; Bos J; van Haelst M; Motazacker MM; Boon EMJ; Santen GWE; Ruivenkamp CAL; Alders M; Luperchio TR; Boukas L; Ramsey K; Narayanan V; Schaefer GB; Bonasio R; Doheny KF; Stevenson RE; Banka S; Sadikovic B; Fahrner JA NPJ Genom Med; 2021 Nov; 6(1):100. PubMed ID: 34819528 [No Abstract] [Full Text] [Related]
6. Identification of DNA methylation episignature for the intellectual developmental disorder, autosomal dominant 21 syndrome, caused by variants in the CTCF gene. Karimi K; Mol MO; Haghshenas S; Relator R; Levy MA; Kerkhof J; McConkey H; Brooks A; Zonneveld-Huijssoon E; Gerkes EH; Tedder ML; Vissers L; Salzano E; Piccione M; Asaftei SD; Carli D; Mussa A; Shukarova-Angelovska E; Trajkova S; Brusco A; Merla G; Alders MM; Bouman A; Sadikovic B Genet Med; 2024 Mar; 26(3):101041. PubMed ID: 38054406 [TBL] [Abstract][Full Text] [Related]
7. Functional Insight into and Refinement of the Genomic Boundaries of the van der Laan L; Rooney K; Haghshenas S; Silva A; McConkey H; Relator R; Levy MA; Valenzuela I; Trujillano L; Lasa-Aranzasti A; Campos B; Castells N; Verberne EA; Maas S; Alders M; Mannens MMAM; van Haelst MM; Sadikovic B; Henneman P Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762546 [No Abstract] [Full Text] [Related]
8. DNA methylation episignature in Gabriele-de Vries syndrome. Cherik F; Reilly J; Kerkhof J; Levy M; McConkey H; Barat-Houari M; Butler KM; Coubes C; Lee JA; Le Guyader G; Louie RJ; Patterson WG; Tedder ML; Bak M; Hammer TB; Craigen W; Démurger F; Dubourg C; Fradin M; Franciskovich R; Frengen E; Friedman J; Palares NR; Iascone M; Misceo D; Monin P; Odent S; Philippe C; Rouxel F; Saletti V; Strømme P; Thulin PC; Sadikovic B; Genevieve D Genet Med; 2022 Apr; 24(4):905-914. PubMed ID: 35027293 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation episignature testing improves molecular diagnosis of Mendelian chromatinopathies. Kerkhof J; Squeo GM; McConkey H; Levy MA; Piemontese MR; Castori M; Accadia M; Biamino E; Della Monica M; Di Giacomo MC; Gervasini C; Maitz S; Melis D; Milani D; Piccione M; Prontera P; Selicorni A; Sadikovic B; Merla G Genet Med; 2022 Jan; 24(1):51-60. PubMed ID: 34906459 [TBL] [Abstract][Full Text] [Related]
10. TET3 dioxygenase modulates gene conversion at the avian immunoglobulin variable region via demethylation of non-CpG sites in pseudogene templates. Takamura N; Seo H; Ohta K Genes Cells; 2021 Mar; 26(3):121-135. PubMed ID: 33421268 [TBL] [Abstract][Full Text] [Related]
14. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Gu TP; Guo F; Yang H; Wu HP; Xu GF; Liu W; Xie ZG; Shi L; He X; Jin SG; Iqbal K; Shi YG; Deng Z; Szabó PE; Pfeifer GP; Li J; Xu GL Nature; 2011 Sep; 477(7366):606-10. PubMed ID: 21892189 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation episignature and comparative epigenomic profiling of HNRNPU-related neurodevelopmental disorder. Rooney K; van der Laan L; Trajkova S; Haghshenas S; Relator R; Lauffer P; Vos N; Levy MA; Brunetti-Pierri N; Terrone G; Mignot C; Keren B; de Villemeur TB; Volker-Touw CML; Verbeek N; van der Smagt JJ; Oegema R; Brusco A; Ferrero GB; Misra-Isrie M; Hochstenbach R; Alders M; Mannens MMAM; Sadikovic B; van Haelst MM; Henneman P Genet Med; 2023 Aug; 25(8):100871. PubMed ID: 37120726 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis. Carella A; Tejedor JR; García MG; Urdinguio RG; Bayón GF; Sierra M; López V; García-Toraño E; Santamarina-Ojeda P; Pérez RF; Bigot T; Mangas C; Corte-Torres MD; Sáenz-de-Santa-María I; Mollejo M; Meléndez B; Astudillo A; Chiara MD; Fernández AF; Fraga MF Int J Cancer; 2020 Jan; 146(2):373-387. PubMed ID: 31211412 [TBL] [Abstract][Full Text] [Related]
17. Germline pathogenic variants in HNRNPU are associated with alterations in blood methylome. Lee S; Ochoa E; Badura-Stronka M; Donnelly D; Lederer D; Lynch SA; Gardham A; Morton J; Stewart H; Docquier F; Rodger F; Martin E; Toribio A; Maher ER; Balasubramanian M Eur J Hum Genet; 2023 Sep; 31(9):1040-1047. PubMed ID: 37407733 [TBL] [Abstract][Full Text] [Related]
18. New insights into DNA methylation signatures: SMARCA2 variants in Nicolaides-Baraitser syndrome. Chater-Diehl E; Ejaz R; Cytrynbaum C; Siu MT; Turinsky A; Choufani S; Goodman SJ; Abdul-Rahman O; Bedford M; Dorrani N; Engleman K; Flores-Daboub J; Genevieve D; Mendoza-Londono R; Meschino W; Perrin L; Safina N; Townshend S; Scherer SW; Anagnostou E; Piton A; Deardorff M; Brudno M; Chitayat D; Weksberg R BMC Med Genomics; 2019 Jul; 12(1):105. PubMed ID: 31288860 [TBL] [Abstract][Full Text] [Related]
19. Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders. Lee S; Menzies L; Hay E; Ochoa E; Docquier F; Rodger F; Deshpande C; Foulds NC; Jacquemont S; Jizi K; Kiep H; Kraus A; Löhner K; Morrison PJ; Popp B; Richardson R; van Haeringen A; Martin E; Toribio A; Li F; Jones WD; Sansbury FH; Maher ER Hum Mol Genet; 2023 Nov; 32(22):3123-3134. PubMed ID: 37166351 [TBL] [Abstract][Full Text] [Related]
20. Clinico-biological refinement of BCL11B-related disorder and identification of an episignature: A series of 20 unreported individuals. Sabbagh Q; Haghshenas S; Piard J; Trouvé C; Amiel J; Attié-Bitach T; Balci T; Barat-Houari M; Belonis A; Boute O; Brightman DS; Bruel AL; Caraffi SG; Chatron N; Collet C; Dufour W; Edery P; Fong CT; Fusco C; Gatinois V; Gouy E; Guerrot AM; Heide S; Joshi A; Karp N; Keren B; Lesieur-Sebellin M; Levy J; Levy MA; Lozano C; Lyonnet S; Margot H; Marzin P; McConkey H; Michaud V; Nicolas G; Nizard M; Paulet A; Peluso F; Pernin V; Perrin L; Philippe C; Prasad C; Prasad M; Relator R; Rio M; Rondeau S; Ruault V; Ruiz-Pallares N; Sanchez E; Shears D; Siu VM; Sorlin A; Tedder M; Tharreau M; Mau-Them FT; van der Laan L; Van Gils J; Verloes A; Whalen S; Willems M; Yauy K; Zuntini R; Kerkhof J; Sadikovic B; Geneviève D Genet Med; 2024 Jan; 26(1):101007. PubMed ID: 37860968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]